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INTRODUCTION
Facial skin dryness
To this day, dry skin is the number one 
unmet skincare consumer need glob-
ally. Thus, our aim is to understand in 
more depth the moisturization of the 
skin but also the needs of the differently 
pigmented skin types. Although various 
controversial data exist, it seems that 
the barrier of darkly pigmented skin has 
some advantages compared with that 
of lightly-pigmented skin. Most studies 
have been conducted on volar forearms, 
but our interest is facial skin.
Facial skin is unique in that it receives 
far more exposure to the external en-
vironment than skin on other areas of 
the body. Paradoxically, the stratum cor-
neum of the face is particularly sensi-
tive and thinner than elsewhere in the 
body [1] with the eye region having a 
stratum corneum as thin as 6 μm [2]. 
Environmental influences contribute 
to drying of facial skin but also dam-
age to the stratum corneum [3]. There 
are fewer cell layers and smaller cor-
neocytes than on most other body sites 
[4]. Whereas on the forearm there are 
approximately 15 - 20 cell layers, facial 
stratum corneum has only approximate-
ly 7 -10 cell layers [5]. Compared to other 
body sites, facial skin shows elevated 
transepidermal water loss (TEWL), in-
creased stratum corneum cohesion and 
higher proteolytic activity resulting in 
premature corneodesmosomal degra-
dation and stratum corneum thinning.
Our recently developed color mapping 
analysis of bio-instrumental evaluations 
[6] enabled a continuous visualization of 
facial skin moisturization (Figure  1). We 
have concluded that a) remarkable gra-
dients of skin hydration and TEWL exist 
within short distances and b) the gra-
dients are distinctive in different ethnic 
groups. A four-week study using a cream 
with high levels of bench mark moistur-
izers led to a general improvement in hy-
dration. However, relative to other facial 
sites, the moisturization of the nasolabial 
fold and parts of the cheek remained in-
adequate [7]. This study highlighted the 
complexity of facial skin and properties 
among different ethnic groups, which 
might be the reason why dry facial skin 
Abstract
Dry skin is one of the most important 
concerns of consumers worldwide. 
Despite huge efforts over several de-
cades, the personal care industry still 
does not offer complete solutions that 
satisfy the unmet needs of consum-
ers for moisturizing treatments. The 
paucity of data for the underlying bio-
chemical problems in and the effects 
of moisturizers on facial skin biology 
and physiology may partly explain 
this. Our recent color mapping stud-
ies based on bio-instrumental evalua-
tions of skin capacitance and transepi-
dermal water loss have revealed the 
complexity of facial skin. However, 
the biomolecular reasons for these 
subtle differences in the different 
zones of the face are unknown so 
far. As the maturation of the stratum 
corneum is vital for skin moisturiza-
tion and optimal barrier function, we 
believe that the protease / protease-
inhibitor balance particularly of the 
plasminogen system may be key in 
these processes. Thus, our aim was 
to develop a specific dual plasmin and 
urokinase inhibitor for topical appli-
cation to barrier-impaired skin and 
demonstrate its efficacy.
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Stratum corneum proteases
Enzymes, in particular proteases, play 
important roles in lipid barrier homeosta-
sis, tissue remodeling and inflammatory 
conditions but are also involved in the 
keratinization process [10]. Epidermal 
proteases control desquamation, cor-
neocyte maturity and the number of cell 
layers in the stratum corneum. Changes 
in the proteolytic balance of the skin can 
result in inflammation, which leads to 
the typical somatosensory signs of red-
ness, scaling, and itching. The activity of 
certain proteases is increased in skin dis-
orders in which the epidermal barrier is 
impaired [11, 12], ranging from genetic 
diseases, such as psoriasis and atopic 
dermatitis, to subclinical barrier abnor-
malities induced, for example, by alka-
line soaps or environmental influences 
[13]. This imbalance in protease activity 
causes structural changes in the stratum 
corneum and their excess can lead to 
activation of inflammatory pathways.
Desquamation of corneocytes can on-
ly occur once the extracellular part of 
corneodesmosomes, the cadherins, has 
been hydrolyzed, allowing a regulated 
shedding of corneocytes [11]. This is a 
very complex cascade in which mainly 
kallikreins (serine proteases), but also 
cathepsins (cysteine and aspartic prote-
ases) and heparanase 1 (an endoglycosi-
dase), are involved. Activities of desqua-
matory proteases are kept under control 
by several endogenous inhibitors, mainly 
lymphoepithelial Kazal-type inhibitors 
(LEKTI) [14, 15].
The proteases of the plasminogen sys-
tem in the epidermis are activated by 
inflammatory conditions, such as UV 
light [16] [17], or by proinflammatory 
cytokines, such as IL-1β, IL-8 and TNFα 
[18, 19]. Plasminogen is activated to 
plasmin by plasminogen activators, such 
as urokinase (Figure  2). Katsuta et al. 
found that urokinase itself is immedi-
ately activated in the stratum corneum 
after barrier disruption [20]. Activated 
plasmin then leads to premature des-
quamation, impaired maturation of 
cornified envelopes and delayed barrier 
recovery. Moreover, plasmin activates 
proMMPs, which can lead to destruc-
is still a major unmet consumer need. The 
biomolecular causes for these differenc-
es in the different zones of the face are 
unknown to date. Obviously, a deeper 
molecular understanding of the stratum 
corneum is needed.
Surprisingly, it was only 29 years ago 
that Warner and colleagues demon-
strated for the first time a water con-
centration profile within the epidermis 
[8]. They showed that there is a steep 
water gradient in the stratum corneum 
reaching a plateau level in the living epi-
dermis. Based on these data it can be 
estimated that dry body skin needs only 
3 ml of water to become well hydrated 
and dry facial skin as little as 100 μl, 
corresponding to 2 drops of water. So, 
why is it then that we still fail to mois-
turize dry skin reliably, effectively, and 
sustainably when such tiny amounts 
of water are required, especially if we 
consider the water movements through 
our skin which run in much larger di-
mensions (sweat and TEWL, more than 
200 ml / day each)?
All these facts call for novel concepts 
for the treatment of dry skin. A promis-
ing approach can be found in Rawlings’ 
moisturizing review in the IFSCC Maga-
zine [9]. He concluded that the biology of 
skin moisturization, of which hydration 
is only one benefit, is highly complex and 
that the future of all new moisturizers lies 
in understanding the control of desqua-
mation.
Figure  1  a) Composite facial images of Caucasian, Black African and Indian subjects (from left); below, 
continuous facial color mapping of skin capacitance b) baseline, and c) after a four-week moisturizer 
treatment. Color codes for corneometer values (AU) are shown on the scales; capacitance 15-80 AU, 
blue = normal skin condition, red = impaired skin condition.
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tion of components of the extracellular 
matrix (ECM) and the dermal-epidermal 
junction (DEJ) [21]. Thus, the activation 
of the plasminogen system is detrimen-
tal for epidermal homeostasis. It is pro-
posed to be the major protease activity 
involved in the delay of barrier recovery 
[20, 22, 23, 24]. Obviously, the inhibition 
of the plasminogen system will lead to 
improved barrier function and reduced 
ECM and DEJ degradation.
To our knowledge, there is no evidence 
for corneodesmosomal degradation by 
urokinase or plasmin. However, there 
are indications that the plasminogen sys-
tem can activate certain pro-kallikreins 
and vice versa, which may lead to abnor-
mal desquamation and may play a role in 
inflammatory skin diseases [25].
A tape stripping based depth profiling 
of desquamatory kallikreins and prote-
ases of the plasminogen system in the 
stratum corneum of healthy Caucasian 
subjects revealed significantly increased 
activities of all the tested proteases on 
the cheek versus forearm (Figure  3) [4]. 
Kallikrein 7 was elevated two and kal-
likrein 5 three and a half times versus 
forearm, and the inflammatory prote-
ases urokinase five and plasmin seven 
times. Later, we found a highly signifi-
cant correlation of plasmin activity with 
TEWL (Figure 4) [26].
In a further study, the proteolytic activ-
ity in the stratum corneum of eczema 
patients was evaluated [12]. All tested 
serine protease activities were signifi-
cantly enhanced in lesional skin. Com-
pared with healthy skin, kallikrein 7 ac-
tivity was double and kallikrein 5 activity 
was increased five and urokinase activ-
ity eight times in lesional skin. Interest-
ingly, these are approximately the same 
fold increases we found on the cheek 
of healthy subjects. The plasmin activ-
ity, however, was massively elevated 
in lesional skin: 30 times versus non-
lesional and 70 times versus healthy skin 
(Figure  5). Moreover, there was a sig-
nificant reduction of stratum corneum 
thickness in lesional skin.
The epidermal plasminogen system is ac-
tivated in inflammatory conditions, even 
in subclinical, micro- or pre-inflammatory 
conditions, and in UV damaged skin. We 
believe that the plasminogen system is a 
key marker for underlying and sometimes 
non-observable barrier abnormalities but 
also an indicator of epidermal photodam-
age [27]. Thus, our aim was to develop 
a novel treatment for topical application 
to barrier-impaired facial skin based on 
a specific dual plasmin and urokinase in-
hibitor and show its efficacy in silico, in 
vitro and in vivo. The face represents a 
particular challenge. It has a low barrier 
reserve and needs special care to main-
tain its barrier function.
Figure  2  Activation cascade of the plasminogen system and its impact on desquamation, cornified 
envelope (CE) maturation, barrier recovery and components of the extracellular matrix (ECM) and the 
dermal-epidermal junction (DEJ).
Figure  3  Fold increase (cheek vs. forearm) of protease activities in extracts of tape strippings taken 
from Caucasian subjects.
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tion with a polyclonal rabbit antibody for 
plasmin (#ab48350, Abcam, Cambridge, 
UK) the staining was detected with Dako 
Real Detection System (#K5005, DAKO, 
Glostrup, DK). The sections were coun-
terstained with hematoxylin (#MHS80, 
Sigma-Aldrich, St. Louis, US) and mount-
ed. Slides were photographed using an 
Olympus BX51 microscope equipped 
with an Olympus DP70 camera, at 200 × 
magnification. Twelve bright field images 
were acquired for each treatment. The 
amount of the antigen present in each 
slide was evaluated by estimating the in-
tensity and the distribution of the red 
staining within the epidermis using Im-
ageJ software (NIH, USA). The obtained 
data were normalized upon the dimen-
sion of the analyzed surface expressed in 
pixels, thus obtaining a semi-quantitative 
score for each image. Briefly, after back-
ground subtraction, a custom-modified 
color deconvolution matrix was applied 
to each picture in order to separate the 
color pictures according to the analysis 
needs. The obtained red channel pictures 
were selected and transformed into 8-bit 
images. The epidermis area was then se-
lected in each image and the intensity 
and distribution of staining within the 
selected area was estimated and normal-
ized on its dimension.
Stratum corneum protease profiling
and corneocyte envelope phenotype
studies from tape strippings
For protease profiling, tape strippings 
were taken from the sun-protected post-
auricular site and sun-exposed cheek of 
sixty healthy female volunteers living in 
Pretoria, South Africa [27]. There were 
three age-matched groups (n = 20 each) 
of Albino African (40 ± 3 years), Black 
African (38 ± 2 years) and Caucasian sub-
jects (45 ± 3 years). Tape stripping extracts 
(0.1 M TRIS/HCl buffer, pH 8.0, contain-
ing 0.5 % Triton X-100) were assayed 
for the activity of plasmin by use of the 
aminomethylcoumarin-based fluorogenic 
peptide substrate (MeOSuc-Ala-Phe-Lys-
AMC) and HPLC. Corneocyte maturation 
was evaluated by Nile red and involucrin 
antibody staining with a fluorescence 
microscope equipped with a Canon 70D 
camera. IMAGEJ™ image analysis soft-
ware was used to analyze the red pixels 
 
METHODS
UV induction of plasmin ex vivo
For immunohistochemical evaluation 
of UV induction of plasmin, biopsies 
of excised abdominal human skin were 
radiated with a Bio-Sun solar simula-
tor (Vilber-Lourmat, Eberhardzell, DE). 
The skin samples were irradiated with 
3  Jcm-2 in total, composed as follows: 
0.1  Jcm-2 UVB (312 nm) and 2.9  Jcm-2 
UVA (365 nm). The biopsies were for-
malin fixed, paraffin embedded and cut 
into 5 μm thick sections. The sections 
were then deparaffinized in Kclear plus 
(#1276, Kaltek srl, Padova, IT) and grad-
ed alcohols, followed by specific antigen 
retrieval in EnVision™ FLEX Target Re-
trieval Solution, low pH (#K8005, DAKO, 
Glostrup, DK) in a steamer. After incuba-
Figure  4  Correlation of plasmin and urokinase activities in extracts of tape strippings taken from Cau-
casian subjects and transepidermal water loss (TEWL), p < 0.001 for plasmin and p < 0.05 for urokinase.
Figure  5  Fold increase of protease activities in extracts of tape strippings taken from atopic patients 
and healthy subjects (lesional vs. non-lesional atopic skin and lesional atopic skin vs. healthy skin, 
all p < 0.05). Inlay shows an example of lesional acute eczematous atopic skin.
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obtained from the Nile red-stained cells 
and the green pixels from the immunos-
tained cells.
Synthesis of a plasmin and urokinase
inhibitor and examination of its 
effects in vitro
Peptide coupling methods were used to 
synthesize the inhibitor BSFAB (INCI name: 
Benzylsulfonyl-D-Seryl-Homophenylalanine 
Amidino-Benzylamide Acetate) (Figure  6) 
Figure  6  Chemical structure of BSFAB.
in high purity (> 97 %) [28]. For the evalu-
ation of Ki values of BSFAB, MeOSuc-Ala-
Phe-Lys-AMC was used as the fluorogenic 
substrate for plasmin and Bz-β-Ala-Gly-
Arg-AMC for urokinase.
For in silico docking studies, the catalytic 
domain of plasmin and urokinase were 
retrieved from the protein data bank of 
Research Collaboration for Structural Bio-
informatics (RSCB), PDB codes: 1BUI and 
1VJ9 and prepared for modeling stud-
ies using the protein preparation wizard 
(Maestro version 10.1, Schrödinger, LLC, 
New York, NY, USA) [28]. BSFAB was 
docked to the catalytic domains (Glide, 
version 6.9, Schrödinger, LLC, New York, 
NY, USA) and the Standard Precision (SP) 
setting was used. For docking, multiple 
conformers of BSFAB were generated 
(Confgen, version 3.1, Schrödinger, LLC, 
New York, NY, USA). Among the different 
binding poses generated the best pose, 
based on visual inspection, was refined us-
ing Prime, version 4.2 (Schrödinger, LLC, 
New York, NY, USA).
To demonstrate inhibition of cell-secreted 
proteases, normal human keratinocytes 
were seeded at sub-confluence and 
grown for 24 hours in Cnt-07 plasmin-
free media (CELLnTEC, Bern, CH). The 
cells were stimulated with inflammatory 
cytokines (IL-1β and TNFα, 10 ng/ml each), 
followed by addition of BSFAB (100 μM). 
The proteolytic activities of urokinase and 
Table I  Composition of Vehicle and Active (Hydrogels)
Figure  7  UV-induced expression of plasmin in a) unirradiated (control) and b) UVA/B-irradiated 
(3 J cm-2) excised human skin. Plasmin was immunostained and is indicated by red color, n =12, data 
are the mean ± SEM, * p < 0.05.
plasmin were quantified using previously 
described methods [4, 12] after 48 hours 
of incubation.
Clinical effects of BSFAB 
on barrier function in vivo
Forty-six Caucasian subjects (n = 23 per 
aged matched group, 39 ± 6 years) with 
self-assessed sensitive facial skin partici-
pated in the clinical study. On the 28 days 
of the application phase the subjects ap-
plied a hydrogel, either the vehicle or the 
test formulation (10 ppm BSFAB), twice 
daily to the face (Table I) [28]. Basal TEWL 
was measured and six consecutive stan-
dard D-Squame® disks (CuDerm Corpo-
ration, Dallas, USA) were taken from the 
cheek in order to mechanically challenge 
the barrier. TEWL was measured at base-
line and day 28 and, in order to determine 
the barrier repair and barrier improve-
ment, 24 hours after the tape strippings 
on day 1 and day 29. Before the beginning 
of the study and after four weeks of treat-
ment, the subjects completed a question-
naire with structured scales containing the 
description of skin conditions.
RESULTS AND DISCUSSION
Changes in stratum corneum 
plasmin levels
For the first time, we demonstrated im-
munohistochemically that plasmin is 
significantly upregulated ex vivo in the 
stratum corneum and the stratum granu-
losum after exposure to UVA/B radiation 
(+102 % ± 33 %, p < 0.05) (Figure  7).
Plasmin activity was also shown to be 
increased in vivo on sun-exposed cheek 
stratum corneum in all three subject 
groups, which was statistically significant 
(p < 0.001) in Albino Africans (+107 %) 
and Caucasians (+109 %) (Figure 8). 
On both sun-exposed and sun-protected 
facial sites, the rank order of plasmin ac-
tivity was Albino Africans > Caucasians 
> Black Africans. All interethnic differ-
ences were highly significant (p < 0.001). 
Both photodamage and skin pigmenta-
tion seem to be related to plasmin activ-
ity. Moreover, elevated plasmin activity 
was associated with reduced corneocyte 
maturation (data not shown).
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Synthesis, in silico modeling 
and efficacy of BSFAB
An efficient and cost-effective process 
for the synthesis of BSFAB in high purity 
(97.3 %) and high overall yield (39 %) with-
out any need for ion-exchange chromatog-
raphy was developed. As the catalytic do-
mains of urokinase and plasmin are highly 
conserved, BSFAB inhibits these enzymes 
by a very similar binding mode (Figure  9). 
In both modeled complexes the amidine 
moiety of BSFAB is tightly anchored in the 
S1 pocket by binding to the side chains of 
Asp189 and Ser190 and to the carbonyl 
oxygen of Gly219. The backbone of the P3 
D-Ser residue binds to the NH and carbonyl 
oxygen of Gly216 and one oxygen of the 
sulfonamide group interacts with the NH 
of Gly219. Moreover, the urokinase com-
plex is further stabilized by two additional 
hydrogen bonds between the P3 D-Ser hy-
droxyl group and the carbonyl of Leu97B 
and the side chain of His99.
BSFAB was shown to be an effective and 
reversible inhibitor of both proteases with 
Ki values of 25 nM for urokinase and 29 
nM for plasmin. Moreover, we could dem-
onstrate that BSFAB is a selective inhibitor 
and showed only negligible or no inhibi-
tory potency against other key proteases 
occurring in the stratum corneum, such 
as tryptase or kallikrein 4 and kallikrein 
7, and did not inhibit neutrophil elastase 
in the test conditions used. The Ki’s for 
tryptase were approximately 45 - 80 and 
for kallikrein 5 and kallikrein 7 approxi-
mately 500 - 1000 fold weaker. As the kal-
likreins are vital for desquamation, we do 
not want to influence the desquamatory 
process and induce a rough or dry skin 
condition.
Inflammatory cytokines (IL-1β, TNFα, IL-8) 
are known to increase the activities of 
components of the plasminogen cascade 
[18, 19]. Therefore, we used IL-1β and 
TNFα to stimulate normal human kerati-
nocytes and evaluated the inhibitory effect 
of BSFAB. We established that there was 
a significant reduction, 97 % and 40 %, in 
the activities of urokinase and plasmin, re-
spectively, in both unstimulated and stim-
ulated cells using this inhibitor (100 μM).
Clinically, BSFAB improved facial stratum 
corneum barrier function. Compared with 
day 0, basal TEWL of the BSFAB-treated 
subjects was numerically but nonsignifi-
cantly superior to the vehicle on day 28 
(Figure  10). However, there was a signifi-
cant difference between the two formu-
lations on day 29 with the BSFAB treat-
ment being more resistant to a repeated 
Figure  8  Stratum corneum plasmin activity on the sun-exposed cheek and sun-protected post-
auricular site of differently pigmented ethnicities (Albino Africans, Black Africans, Caucasians). Data 
are the mean ± SEM, *** p < 0.001, n.s., not significant.
Figure  9  Modeled binding modes of BSFAB. Surface view of BSFAB bound to a) urokinase and b) 
plasmin, highlighting the fit of BSFAB into the S1 pocket and the main contact residues. Cartoon view 
of BSFAB bound to the active sites of c) urokinase and d) plasmin, highlighting key polar contacts.
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tape stripping challenge, indicating an 
improvement in the biomolecular archi-
tecture of the stratum corneum and that 
France. Most importantly, we also would 
like to thank all the volunteers who took 
part in the studies.
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CONCLUSION
The enhanced activities of proteases of 
the plasminogen system in the stratum 
corneum are associated with premature 
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maturation [12, 27]. There is evidence that 
the presence of elevated levels of these 
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